Alzheimer's disease was first described in 1906. Since then, scientists have made remarkable strides in understanding how Alzheimer's affects the brain and learning how to make life better for affected individuals and families.
In 2024, Donanemab (Kisunla™) received traditional approval as a treatment for early Alzheimer's from the FDA. It is the second traditionally approved treatment that addresses the underlying biology of Alzheimer's and changes the course of the disease in a meaningful way for people in the early stages.
Slowing down the disease is critical, but we cannot stop here. New and better treatments for Alzheimer's are urgently needed. Continuing to invest in research is the only way we can hope to find a cure for Alzheimer's. It is research that creates breakthroughs and makes advancements toward a cure possible.
My inspiration for Walking is my brother and his wife who were caretakers for her mom who was diagnosed a few years ago. They provided exceptional care for her and were honored that they were able to do this for her.
Please donate to advance the care, support and research efforts of the Alzheimer's Association.
My Progress
Thank you for helping advance Alzheimer's support, care and research.
135
I have raised
500
My Goal
My Video
My Achievements
Self-Donor
Fundraiser
Storyteller
Facebook Fundraiser
10 DONATIONS
25 DONATIONS



